Corinne E Augelli-Szafran

USPTO Granted Patents = 18 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

18 out of 203

Southern Research Institute

patents

5 out of 580

The Uab Research Foundation

patents

4 out of 504

Oregon Health & Science University

patents

4. 1 out of 889

The United States Government As Represented by the Department of Veterans Affairs

patents

5. 1 out of 1,579

Washington University

patents

6. 1 out of 5,444

University of Texas System

patents

7. 1 out of 1,153

Vanderbilt University

patents

8. 1 out of 1,270

The University of North Carolina at Chapel Hill

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486254 - Uracil derivatives for stimulating read-through of premature termination codons (2025-12-02),

2. 12215108 - Development of potential antidotes for arsenicals (2025-02-04),

3. 12103943 - Development of novel clofarabine analogs for cancer therapy (2024-10-01),

4. 11932626 - 2-pyrimidone analogs as potent antiviral agents against Alphaviruses (2024-03-19),

5. 11905306 - Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus (2024-02-20),

6. 11905258 - 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases (2024-02-20),

7. 11858956 - 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections (2024-01-02),

8. 11752153 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2023-09-12),

9. 11718593 - 2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases (2023-08-08),

10. 11578073 - Xanthine analogs as potent anti-West Nile viral agents (2023-02-14),

11. 11566019 - 2-pyrimidone analogs as potent antiviral agents against alphaviruses (2023-01-31),

12. 11524010 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2022-12-13),

13. 11472781 - 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases (2022-10-18),

14. 11103508 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2021-08-31),

15. 11066357 - Benzoannulene derivatives as antiviral agents (2021-07-20),

Title: The Innovative Journey of Corinne E Augelli-Szafran

Introduction: Corinne E Augelli-Szafran, a talented inventor hailing from Homewood, AL (US), has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Corinne E Augelli-Szafran holds several patents in various fields, including biotechnology, healthcare, and environmental sustainability. Her most recent patent focuses on a novel method for sustainable packaging materials that reduce environmental impact.

Career Highlights: With a background in biochemistry and a passion for sustainability, Corinne E Augelli-Szafran has had a remarkable career marked by numerous achievements. She has worked with leading research institutions and companies to develop innovative solutions to pressing global challenges.

Collaborations: Throughout her career, Corinne E Augelli-Szafran has collaborated with top scientists, engineers, and researchers to bring her inventions to life. Her collaborative spirit and dedication to excellence have led to successful partnerships and groundbreaking innovations.

Conclusion: Corinne E Augelli-Szafran's relentless pursuit of innovation and commitment to creating a better world through her inventions make her a true pioneer in the field. Her work continues to inspire and drive positive change in industries around the globe.

This text is generated by artificial intelligence and may not be accurate.